A. Zaremba

发表

Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases.

J. Utikal, S. Haferkamp, D. Schadendorf, 2021, European journal of cancer.

Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis

C. Berking, D. Schadendorf, A. Gesierich, 2021, Frontiers in Oncology.

Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival

D. Schadendorf, P. Jansen, S. Ugurel, 2022, Cancers.

Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology.

D. Schadendorf, P. Jansen, E. Livingstone, 2021, European journal of cancer.

Clinical and genetic analysis of melanomas arising in acral sites.

D. Schadendorf, P. Jansen, T. Brinker, 2019, European journal of cancer.

Frequent Occurrence of NRAS and BRAF Mutations in Human Acral Naevi

J. Klode, D. Schadendorf, P. Jansen, 2019, Cancers.

Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma

D. Schadendorf, S. Ugurel, L. Umutlu, 2022, Cancer Imaging.

Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.

A. Hauschild, K. Kähler, P. Ascierto, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response.

A. Hauschild, K. Kähler, Sarah Schäfer, 2021, European journal of cancer.

Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions

D. Schadendorf, P. Jansen, S. Ugurel, 2022, Cancers.

Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors

D. Schadendorf, P. Jansen, A. Bankfalvi, 2022, International journal of cancer.

TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy.

M. Weichenthal, J. Utikal, D. Schadendorf, 2021, European journal of cancer.

Hematological immune related adverse events after treatment with immune checkpoint inhibitors.

C. Berking, A. Gesierich, K. Kähler, 2021, European journal of cancer.

Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants

D. Schadendorf, P. Jansen, E. Livingstone, 2022, Pigment cell & melanoma research.

Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade: A Case Report

D. Schadendorf, S. Ugurel, A. Wetter, 2020, Frontiers in Oncology.

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma

M. Weichenthal, K. Kähler, P. Ascierto, 2022, Journal for ImmunoTherapy of Cancer.

Genetic characterization of advanced conjunctival melanoma and response to systemic treatment.

D. Schadendorf, P. Jansen, K. Kähler, 2022, European journal of cancer.

GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular Tumors

D. Schadendorf, P. Jansen, M. Gunzer, 2021, Frontiers in Genetics.

NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors.

M. Weichenthal, J. Utikal, D. Schadendorf, 2021, European journal of cancer.

TERT expression is associated with metastasis from thin primaries, exhausted CD4+ T cells in melanoma and with DNA repair across cancer entities

D. Schadendorf, T. Schöneberg, Sven-Holger Puppel, 2023, bioRxiv.

Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma

D. Schadendorf, A. Giobbie-Hurder, E. V. Van Allen, 2022, bioRxiv.

MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma - An evaluation of the multicenter prospective skin cancer registry ADOREG.

M. Weichenthal, J. Utikal, S. Haferkamp, 2022, European journal of cancer.

Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?

D. Schadendorf, J. Becker, S. Ugurel, 2019, Journal of Immunotherapy for Cancer.

Rare TERT Promoter Mutations Present in Benign and Malignant Cutaneous Vascular Tumors

D. Schadendorf, P. Jansen, A. Sucker, 2021, Dermato.

Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task.

Achim Hekler, Carola Berking, Dirk Schadendorf, 2019, European journal of cancer.

A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task.

Achim Hekler, Carola Berking, Dirk Schadendorf, 2019, European journal of cancer.

GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma

J. Utikal, D. Schadendorf, B. Schilling, 2020, The British journal of dermatology.

Fatal swelling of the groin – Clear cell sarcoma: a rare but important differential diagnosis to malignant melanoma

D. Schadendorf, A. Roesch, A. Schulz, 2020, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Evolution of melanoma cross-resistance to CD8+ T cells and MAPK inhibition in the course of BRAFi treatment

S. Haferkamp, D. Schadendorf, B. Schilling, 2018, Oncoimmunology.

The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patients.

D. Schadendorf, S. Ugurel, P. Ascierto, 2021, European journal of cancer.

The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition

D. Schadendorf, B. Győrffy, A. Bankfalvi, 2022, International journal of molecular sciences.

Response to comment - Molecular pathology as a diagnostic aid in difficult to classify melanocytic tumours with spitzoid morphology.

D. Schadendorf, K. Griewank, A. Zaremba, 2021, European journal of cancer.

Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.

D. Schadendorf, S. Ugurel, L. Umutlu, 2021, European journal of cancer.

Characterisation and outcome of RAC1 mutated melanoma.

M. Weichenthal, J. Utikal, D. Schadendorf, 2023, European journal of cancer.

Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG.

M. Weichenthal, J. Utikal, S. Haferkamp, 2023, European journal of cancer.

Pruritus in patients with chronic leg ulcers: A frequent and often neglected problem

S. Ständer, S. Benson, J. Dissemond, 2019, International wound journal.

Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses.

D. Schadendorf, A. Krüger, A. Obenauf, 2023, Immunity.

Frequent Occurrence of NRAS and BRAF Mutations in Human Acral Naevi

J. Klode, D. Schadendorf, P. Jansen, 2019, Cancers.

Tödliche Schwellung der Leiste – Klarzellsarkom: eine seltene, aber wichtige Differenzialdiagnose zum malignen Melanom

D. Schadendorf, A. Roesch, A. Schulz, 2020, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task.

A. Enk, Therezia Bokor-Billmann, K. Buder-Bakhaya, 2019, European journal of cancer.

Characterisation and outcome of RAC1 mutated melanoma.

M. Weichenthal, J. Utikal, D. Schadendorf, 2023, European journal of cancer.

HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistance.

D. Schadendorf, S. Ferrone, A. Roesch, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.